274 related articles for article (PubMed ID: 16507752)
1. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.
Kim JK; Kim SH; Jang YJ; Ahn H; Kim CS; Park H; Lee JW; Kim S; Cho KS
Radiology; 2006 Apr; 239(1):174-80. PubMed ID: 16507752
[TBL] [Abstract][Full Text] [Related]
2. Value of T2-weighted MR imaging in differentiating low-fat renal angiomyolipomas from other renal tumors.
Choi HJ; Kim JK; Ahn H; Kim CS; Kim MH; Cho KS
Acta Radiol; 2011 Apr; 52(3):349-53. PubMed ID: 21498374
[TBL] [Abstract][Full Text] [Related]
3. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?
Hindman N; Ngo L; Genega EM; Melamed J; Wei J; Braza JM; Rofsky NM; Pedrosa I
Radiology; 2012 Nov; 265(2):468-77. PubMed ID: 23012463
[TBL] [Abstract][Full Text] [Related]
4. Double-echo gradient chemical shift MR imaging fails to differentiate minimal fat renal angiomyolipomas from other homogeneous solid renal tumors.
Ferré R; Cornelis F; Verkarre V; Eiss D; Correas JM; Grenier N; Hélénon O
Eur J Radiol; 2015 Mar; 84(3):360-365. PubMed ID: 25547327
[TBL] [Abstract][Full Text] [Related]
5. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.
Sasiwimonphan K; Takahashi N; Leibovich BC; Carter RE; Atwell TD; Kawashima A
Radiology; 2012 Apr; 263(1):160-8. PubMed ID: 22344404
[TBL] [Abstract][Full Text] [Related]
6. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
7. Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors.
Chung MS; Choi HJ; Kim MH; Cho KS
AJR Am J Roentgenol; 2014 Apr; 202(4):765-71. PubMed ID: 24660704
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
10. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of rebound and lymphoid thymic hyperplasia from anterior mediastinal tumors with dual-echo chemical-shift MR imaging in adulthood: reliability of the chemical-shift ratio and signal intensity index.
Priola AM; Priola SM; Ciccone G; Evangelista A; Cataldi A; Gned D; Pazè F; Ducco L; Moretti F; Brundu M; Veltri A
Radiology; 2015 Jan; 274(1):238-49. PubMed ID: 25105246
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 3D two-point Dixon and standard 2D dual-echo breath-hold sequences for detection and quantification of fat content in renal angiomyolipoma.
Rosenkrantz AB; Raj S; Babb JS; Chandarana H
Eur J Radiol; 2012 Jan; 81(1):47-51. PubMed ID: 21126839
[TBL] [Abstract][Full Text] [Related]
14. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT.
Kim JK; Park SY; Shon JH; Cho KS
Radiology; 2004 Mar; 230(3):677-84. PubMed ID: 14990834
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
[TBL] [Abstract][Full Text] [Related]
17. Sonographic Features of Small (< 4 cm) Renal Tumors With Low Signal Intensity on T2-Weighted MR Images: Differentiating Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
Park KJ; Kim MH; Kim JK; Cho KS
AJR Am J Roentgenol; 2018 Sep; 211(3):605-613. PubMed ID: 30040467
[TBL] [Abstract][Full Text] [Related]
18. Unenhanced CT and MRI Parameters That Can Be Used to Reliably Predict Fat-Invisible Angiomyolipoma.
Jeong CJ; Park BK; Park JJ; Kim CK
AJR Am J Roentgenol; 2016 Feb; 206(2):340-7. PubMed ID: 26797361
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
[TBL] [Abstract][Full Text] [Related]
20. [MR imaging features of different renal cell carcinoma subtypes].
Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
